R Stauder
Overview
Explore the profile of R Stauder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nachtkamp K, Strupp C, Vukelja M, Kasprzak A, Haase D, Ganster C, et al.
Leukemia
. 2024 Jan;
38(2):442-445.
PMID: 38263435
No abstract available.
2.
Beer A, Laille E, Neuwirt H, Mayer G, Stauder R
Leuk Lymphoma
. 2020 Oct;
62(3):743-745.
PMID: 33100080
No abstract available.
3.
Kuendgen A, Nomdedeu M, Tuechler H, Garcia-Manero G, Komrokji R, Sekeres M, et al.
Leukemia
. 2020 Jun;
35(3):835-849.
PMID: 32595214
In the current World Health Organization (WHO)-classification, therapy-related myelodysplastic syndromes (t-MDS) are categorized together with therapy-related acute myeloid leukemia (AML) and t-myelodysplastic/myeloproliferative neoplasms into one subgroup independent of morphologic or...
4.
Platzbecker U, Fenaux P, Ades L, Giagounidis A, Santini V, van de Loosdrecht A, et al.
Blood
. 2018 Nov;
133(10):1020-1030.
PMID: 30404811
The heterogeneity of myelodysplastic syndromes (MDSs) has made evaluating patient response to treatment challenging. In 2006, the International Working Group (IWG) proposed a revision to previously published standardized response criteria...
5.
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines
Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascon P, Glaspy J, et al.
Ann Oncol
. 2018 Oct;
29(Suppl 4):iv271.
PMID: 30285221
No abstract available.
6.
Hofer F, Koinig K, Nagl L, Borjan B, Stauder R
Ann Hematol
. 2018 Jul;
97(11):2235-2243.
PMID: 30054708
Prospective data on fatigue in elderly persons with a hematological malignancy are rare. We aimed to determine the prevalence of fatigue and its association with clinical outcome and geriatric impairments...
7.
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines
Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascon P, Glaspy J, et al.
Ann Oncol
. 2018 Feb;
29(Suppl 4):iv96-iv110.
PMID: 29471514
No abstract available.
8.
Buske C, Hutchings M, Ladetto M, Goede V, Mey U, Soubeyran P, et al.
Ann Oncol
. 2017 Dec;
29(3):544-562.
PMID: 29194473
The European Society for Medical Oncology (ESMO) consensus conference on mature B cell lymphomas and chronic lymphocytic leukaemia (CLL) was held on 20 June 2015 in Lugano, Switzerland, and included...
9.
Garcia-Manero G, Sekeres M, Egyed M, Breccia M, Graux C, Cavenagh J, et al.
Leukemia
. 2017 May;
31(12):2799-2806.
PMID: 28546581
Treatment with azacitidine (AZA), a demethylating agent, prolonged overall survival (OS) vs conventional care in patients with higher-risk myelodysplastic syndromes (MDS). As median survival with monotherapy is <2 years, novel...
10.
Garelius H, Johnston W, Smith A, Park S, de Swart L, Fenaux P, et al.
J Intern Med
. 2016 Dec;
281(3):284-299.
PMID: 27926979
Background: The EUMDS registry is an unique prospective, longitudinal observational registry enrolling newly diagnosed patients with lower-risk myelodysplastic syndrome (MDS) from 17 European countries from both university hospitals and smaller...